There has been continuing interest in the development of reversible gastric H + /K + -ATPase inhibitors as anti-ulcer agent to overcome the potential side effects of irreversible inhibitors. 1 Several quinoline analogs have been developed as reversible inhibitors (Scheme 1), [2] [3] [4] [5] [6] and some of them were clinically evaluated. [7] [8] [9] In our laboratories, various substituent modifications of quinoline have been carried out for the purpose of finding novel agents with biological activities. [10] [11] [12] [13] The previous reports indicated that the orientation of 4-(phenylamino) substituent in quinolines was a very important factor in gastric H + /K + -ATPase inhibitory activity. 5 Literature survey indicated that a variety of 3-substituents, which would be an important factor in controlling the orientation of 4-phenylamino substituent could be tolerated. 8, 9 Although a wide spectrum of 3-substituents were tested, there were no precedent of using vinyl group as a 3-substituent.
In this study, various substituted-vinyl groups were introduced at the 3-position of 4-phenylaminoquinoline derivatives to obtain novel gastric H + /K + -ATPase inhibitors. The 4-(phenylamino)-3-vinylquinoline derivatives were prepared using the palladium-catalyzed Heck reaction as a key reaction, 14, 15 and their activities were tested against gastric H + /K + -ATPase in vitro.
Synthesis
The general synthetic pathway for 4-(2-methylphenylamino)-3-vinylquinoline derivatives is outlined in Scheme 2. The reaction of diethyl malonate (1) with triethyl orthoformate (for R 2 = H) or triethyl orthoacetate (R 2 = CH 3 ) gave appropriately substituted compound 2. Further reaction of 2 with appropriate anilines (R 8 = OCH 3 , OCH 2 CF 3 , OCH 2 -CH 2 OCH 3 ) gave the acyclic precursor 3 for the synthesis of quinolone 4. Thermal cyclization of 3 in diphenyl ether gave the quinolone 4, which could be hydrolyzed and decarboxylated by heating in diphenyl ether to provide quinolone 5. The 3-iodoquinolone 6 was obtained by treatment of quinolone 5 with KI/I 2 . 16 The 3-iodoquinolones 6 were aromitized by heating with phosphrous oxychloride to give 4-chloro-3-iodoquinolines 7. Treatment of 4-chloro-3-iodoquinolines 7 with o-toluidine gave 4-(2-methylphenylamino)-3-iodoquinolines 8. As we have been interested in applying palladium chemistry to pyridine 17 and quinoline moiety, 18 palladium-catalyzed Heck reaction with terminal alkenes was performed to afford 3-vinylquinolines 9 (Method A). For introduction of allylamine moiety, the amino group was protected with Boc group to prevent formation of p-allyl palladium complex with allylic amine substrates. The Boc group of the Heck coupling products was deprotected by trifluoroacetic acid (Method B). This reaction has proven to be quite general. The (E)-stereochemistry of the products was assigned by mechanistic assumption.
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Biological Activity
The in vitro inhibitory activity of the 3-vinylquinoline derivatives on gastric H activity, the substitution with allylic amine moiety retained some activity (9d). Further modification of side chain phenyl group, either substitution at 2-position (9i, 9k) or to change to pyridine (9m), did not improve the activity. It was noted that 2-methoxy (9k) group which can make H-bond to allylic amino proton helped to regain the activity. Changing the aniline group to benzylamino, phenoxy or sulfoxide did not provide improved activities (9p, 9q, 9s, 9u).
Although substitution at 2-position was expected to be detrimental, 9 the introduction of 2-methyl group to 9d to obtain 9g gave a 20-fold increase in inhibitory activity. It was suspected that the loss of activity in earlier study arose 
as a consequence of the perturbation of the conformation of the 4-arylamino group through a steric interaction with the 3-acyl group. In this study, the introduction of 2-methyl group was successful for 9g and 9n, and somewhat helpful for 9t and 9v, but not for 9j, 9l, and 9r. This remarkable difference may come from the different spatial arrangement between acyl moiety and vinyl moiety. The 8-position of the quinoline ring was known to tolerate a very wide variety of substituents with rather minimal steric constraints. 5 Thus modifications at this position was expected to have little effect on in vitro potency, and the main emphasis would be to manipulate the physicochemical properties of the molecule to further optimize in vivo activity. Unfortunately, modification of 8-methoxy group to hydroxyl, trifluoroethoxy, or hydroxyethoxy group (9e, 9f, 9h, 9o) was all detrimental to the activity.
In conclusion, the diverse 4-(2-methylphenylamino)-3-vinylquinoline derivatives were synthesized by intermolecular Heck reaction with terminal alkene substrates. While the compounds substituted by allylamine group at 3-position of quinoline moiety showed improved activities, the compounds substituted with hydroxyethoxy group at 8-position gave lower activities compared to the methoxy substituted compounds. 
Experimental Section
The 1 H NMR spectra were obtained on a Varian Gemini 200 MHz NMR Spectrometer. The GC-MS spectra were obtained on a Shimazu QP 1000 GC/MS. Melting points were determined on MUL-TEM apparatus and were uncorrected. All chemicals were used directly as obtained from commercial sources unless otherwise noted. The H + /K + -ATPase-inhibitory and gastric antisecretory activity were tested by the reported methods.
17 Compounds 2-7 were prepared according to the literature procedures. 8 Where R2 is not hydrogen or R8 is not methoxy, the procedure was slightly modified by using the appropriate reagents. For R8 = OCH2CH2OH, they were prepared by obtaining 9 (R8 = OCH2CH2OCH3) followed by demethylation with BBr3.
4-Chloro-3-iodo-8-methoxyquinoline (7)
. A mixture of 3-iodo-8-methoxy-1H-quinoline-4-one (6, 30.1 g, 0.1 mol) in 80 mL of phosphorus oxychloride was heated under reflux for 1 h, and slowly added to ice-water after cooling. The mixture was neutralized with dilute NaOH solution. The precipitate thus obtained was filtered and dried to afford 30.3 g (95%) of the product: 3-(2-Ethoxycarbonyl-1-ethenyl)-8-methoxy-4-(2-methylphenylamino) quinoline (9b). Palladium acetate (24 mg, 0.1 mmol), (n-Bu) 4 NCl (480 mg, 2 mmol), KOAc (400 mg, 4 mmol), ethyl vinylacetate (400 mg, 4.0 mmol), 3-iodo-4-(2-methylphenylamino)-8-methoxyquinoline (780 mg, 4 mmol), and DMF (40 mL) were added to a pressure tube equipped with a stirring bar. After heating the reaction mixture for 2 h at 100 ºC, the resulting solution was diluted with ethyl acetate and washed with saturated aqueous ammonium chloride. The organic layer was dried over MgSO 4 , filtered, and concentrated. The residue was purified by column chromatography to provide 9b in 30% yield as oil: -ATPase was prepared from the fundic mucosae of New Zealand white rabbits (2-3 Kg, male) as described previously. 13 The mucosal layer of the gastric fundus was scraped, and homogenized in 40 mM Tris/HCl, pH 7.4 containing 0.25 M sucrose, 2 mM HEPEs, 2 mM MgCl 2 , 2 mM EDTA. The homogenate was centrifuged at 10,000 × g for 30 min at 
